3
Total investments
2
Early stage
0
Mid stage
0
Late stage
4y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Advisor
Jun 2026
Rooted in advertising, we develop and produce films with a structured approach that integrates live action, post-production, and AI-driven workflows into one cohesive process.
Angel Investor
Sep 2023
Reliant AI is built to tackle the biggest information challenges in biopharma.
We know that unlocking critical insights can take a tremendous amount of time and effort. Reliant AI builds the most precise applied artificial intelligence tools for the life sciences. Our technology helps biopharma professionals accelerate their work, providing them with high-quality, actionable insights in a fraction of the time without compromising quality.
By combining deep expertise in reinforcement learning, natural language processing, biomedical sciences, and commercialization, we bring the power of generative AI to the most complex problems in biopharma and the life sciences.
Reliant AI was founded by experts from DeepMind, Oxford, and leading research institutions, with backgrounds spanning reinforcement learning, biomedical sciences, and life sciences strategy. Together, they bring world-class expertise to make generative AI practical for the most complex challenges in pharma.
Experience · 6 entries
All (6)
Investments (3)
Founder (2)
2026
Investor & Advisor
Jun 2026
Rooted in advertising, we develop and produce films with a structured approach that integrates live action, post-production, and AI-driven workflows into one cohesive process.
2025
Founder & Managing Director
Jul 2025
Strategic advisory working with senior leaders and owners, particularly during moments of transition and transformation.
Offerings include:
• CXO transition coaching and onboarding support
• CXO sparring on complex performance transformations and execution
• Growth and go-to-market strategy grounded in digital and analytics including organizational realignment
Co-Founder & Managing Director
Jul 2025
Exzellenz trifft Ambition – von Deutschlands Besten die Geheimnisse der Peak Performance lernen.
Peaksphere.com ermöglicht Sportenthusiasten, Eltern und Trainern den direkten Zugang zu progressionskritischem Expertenwissen von ausschließlich verifizierten Leistungsträgern aus der deutschen Spitzensportlandschaft – unseren „Unlocking Experts“.
Dabei geht es nicht um allgemeine Creator-Motivation, sondern um individuelle, zielgerichtete Impulse genau zum richtigen Zeitpunkt im persönlichen sportlichen Entwicklungsprozess. Direkt. Echt. Wirksam. Statt pauschaler Online-Weisheiten oder ineffizientem Trial & Error erleben Nutzer:innen ungefilterten Einblick in den professionellen Trainingsalltag und den direkten Austausch sowie Analysen per Video Session – direkt mit den Besten ihrer Disziplin.
Peaksphere transformiert das Wissen der Spitze in konkrete Fortschritte für die Breite – und schafft gleichzeitig effektive Monetarisierungsoptionen für Spitzensportler:innen.
2023
Angel Investor
Sep 2023
Reliant AI is built to tackle the biggest information challenges in biopharma.
We know that unlocking critical insights can take a tremendous amount of time and effort. Reliant AI builds the most precise applied artificial intelligence tools for the life sciences. Our technology helps biopharma professionals accelerate their work, providing them with high-quality, actionable insights in a fraction of the time without compromising quality.
By combining deep expertise in reinforcement learning, natural language processing, biomedical sciences, and commercialization, we bring the power of generative AI to the most complex problems in biopharma and the life sciences.
Reliant AI was founded by experts from DeepMind, Oxford, and leading research institutions, with backgrounds spanning reinforcement learning, biomedical sciences, and life sciences strategy. Together, they bring world-class expertise to make generative AI practical for the most complex challenges in pharma.
2022
Angel Investor
Jan 2022
Forget old-school access management. Govern access to every app & AI agent on autopilot — while enabling your teams. 🤖🍰
Show all 6 entries ↓
Investment activity
2022–2026 · 3 investments
Recent (last 2 years)Earlier
